The National Institute of Cannabis Investors says 2019 is the biggest year yet for CBD.
Thanks to the 2018 Farm Bill, the CBD sector has the potential to grow by more than 3,000%.
That makes these the three best CBD oil stocks...
by Daniel Smoot
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
Four-time Stanley Cup Winner Darren McCarty just partnered with cannabis company Pincanna.
And it’s yet another massive buy signal for the best marijuana stocks to buy in 2019.
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
To help our readers cash in on the explosive CBD market, we’re bringing you three of the top CBD stocks to invest in now.
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
The Dow Jones has lost more than 1,000 points since this time last month, and the S&P 500 is down 2.4% for the same time period.
by Greg Miller
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
The past few months have seen some minor scandals push marijuana shares’ prices down, which is natural in a new industry like this.
Aphria, however, zoomed to an intraday high of $7.45 after announcing earnings.
The company increased its net cannabis revenue by 85%, which is a big deal – and it won’t be the only cannabis firm to do that.
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
2019 is a massive year for CBD. To help our readers cash in on this lucrative opportunity, we’re bringing you three of the best CBD stocks to watch in 2019.
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
Our Technical Trading Specialist is looking at all the big earnings plays ahead during this crucial week for the markets as earnings season comes to a close.
by Greg Miller
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
Aphria reported its fiscal fourth-quarter earnings last week, and the company exceeded all expectations.
And it beat those estimates from underneath a cloud of short sellers' spurious innuendo, to boot.
After a quarter of overall decline in Canadian cannabis revenue, Aphria saw an increase of 85% – that's 85% sequentially and not year over year. The company also turned earnings before interest, tax, depreciation, and amortization (EBITDA) positive – albeit after adjustments and with help from a European pharmaceutical distribution business the company owns.
And to top it off, management's optimistic about the future.
So any investor could look at Aphria's reporting and conclude it had a great quarter. And they'd be dead on.
What might not be so obvious at first glance is that this company just showed investors how it was going to take the cannabis sector to the next level.
There’s much more here than meets the eye…
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
2019 is the biggest year yet for CBD. To help you capitalize on this lucrative opportunity, we’re bringing you our top CBD stocks to buy today.
by Greg Miller
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
For a supposedly "controversial" sector, legal cannabis has been refreshingly transparent and light on (actual) scandal, especially compared to, say, finance.
But there's always one…
CannTrust Holdings is a licensed cannabis producer in Canada; It's a popular stock that's seen 2019 highs of CA$14.87 (US$11.24) a share…
And those shares have slid 56% over the past month because of a mounting scandal.
There are $40 million worth of CannTrust products involved – and countless millions more in capital in play here.
Investors are wondering, so I'm going to show you what's happening here...
Start the conversation